Antibody class-switching as a strategy to improve HIV-1 neutralization.

Scheepers C, Richardson SI, Moyo-Gwete T, Moore PL. Antibody class-switching as a strategy to improve HIV-1 neutralization. Trends Mol Med. 2022;28(11):979-88. https://www.cell.com/trends/molecular-medicine/pdf/S1471-4914(22)00215-5.pdf

Peter Matlawa2023-03-01T09:11:52+02:00March 1st, 2023|

Related Posts

Frequent vegetable consumption is inversely associated with hypertension among indigenous Africans. Eur J Prev Cardiol. 2022;29(18):2359-71

Frequent vegetable consumption is inversely associated with hypertension among indigenous Africans. Eur J Prev Cardiol. 2022;29(18):2359-71

Performance of glucagon stimulation test in diagnosing central adrenal insufficiency in children when utilising the Roche Elecsys(®) cortisol II assay: a pilot study.

Performance of glucagon stimulation test in diagnosing central adrenal insufficiency in children when utilising the Roche Elecsys(®) cortisol II assay: a pilot study.

Measles incidence in South Africa: a six-year review, 2015-2020.

Measles incidence in South Africa: a six-year review, 2015-2020.

The association of antibody immunity with cryptococcal antigenemia and mortality in a South African cohort with advanced HIV disease.

The association of antibody immunity with cryptococcal antigenemia and mortality in a South African cohort with advanced HIV disease.

Development of a synthetic nanoparticle vaccine presenting the HIV-1 envelope glycoprotein.

Development of a synthetic nanoparticle vaccine presenting the HIV-1 envelope glycoprotein.